HomeALRN • NASDAQ
Follow
Aileron Therapeutics Inc
Previous close
$7.09
Day range
$6.44 - $6.95
Year range
$1.01 - $7.12
Market cap
32.25M USD
Avg Volume
29.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.98M | -69.50% |
Net income | -1.83M | 71.31% |
Net profit margin | — | — |
Earnings per share | -0.40 | 71.36% |
EBITDA | -1.96M | 69.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.07M | -52.63% |
Total assets | 12.82M | -52.92% |
Total liabilities | 1.62M | -64.20% |
Total equity | 11.20M | — |
Shares outstanding | 4.54M | — |
Price to book | 2.87 | — |
Return on assets | -36.87% | — |
Return on capital | -41.20% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -1.83M | 71.31% |
Cash from operations | -1.64M | 76.47% |
Cash from investing | 542.00K | -87.04% |
Cash from financing | — | — |
Net change in cash | -1.10M | 60.63% |
Free cash flow | -1.01M | 77.93% |
About
Founded
2001
Headquarters
Website
Employees
6